All Locations

Top Companies in Switzerland

344 companies based in Switzerland, sorted by total funding raised.

RhyGaze

Gene therapy company focused on ophthalmology applications, based in Basel and Philadelphia.

Basel, SwitzerlandBiotech, Healthcare
Series A·$96.0M·Jan 2025
Oculis Holding AGIPO

Clinical-stage biopharmaceutical company developing innovative therapies for ophthalmic diseases ...

Reykjavik, Switzerland51–200Biotech, Healthcare
Series C·$92.9M·May 2021
FunPlus

FunPlus is a global mobile game developer and publisher headquartered in Switzerland, with studio...

Zug, Switzerland1001–5000
Series B·$87.0M·Mar 2014
Vvardis

Swiss biomimetic oral care company developing patented dental technologies to treat early caries ...

SwitzerlandHealthcare, Medical Devices
Growth Equity·$85.0M·Apr 2026
Frontify

Brand management platform helping organizations centralize brand guidelines, digital assets, and ...

St. Gallen, Switzerland201–500Marketing Tech, Productivity
Series C·$80.6M·Sep 2021
RoomPriceGenie

AI-powered hotel revenue management SaaS that automates room pricing to optimize occupancy and bo...

Steinhausen, SwitzerlandRevenue Management, SaaS
Growth Equity·$77.2M·Feb 2025
Mimic

Enterprise ransomware defense platform that detects, deflects, and recovers from AI-driven ransom...

Zurich, Switzerland51–200Artificial Intelligence, Cybersecurity
Series A·$77.0M·Feb 2025
CDR-Life

CDR-Life develops highly selective T-cell engagers targeting hard-to-treat solid tumors using an ...

Basel, SwitzerlandBiotech
Series A·$76.0M·Apr 2022
PregLemAcquired

Women's health therapies for gynecological conditions

Geneva, Switzerland11–50Biotech, Healthcare
Series B·$75.8M·Jan 2012
ID QuantiqueAcquired

Quantum-safe cryptography technology

Geneva, Switzerland201–500Cybersecurity
Growth Equity·$75.7M·Feb 2025
Bcomp

Switzerland-based provider of natural fibre-based sustainable lightweighting solutions

Fribourg, Switzerland51–200Mobility, Advanced Manufacturing
Series C·$75.0M·Apr 2024
Mootral

Biotech company developing natural feed supplements that reduce methane emissions from livestock ...

Abertillery, Switzerland11–50Biotech, Climate Tech
Venture Round·$72.8M·Jan 2024
Terra Quantum

Terra Quantum is a deep tech pioneer, developing revolutionary quantum applications to shape the ...

Switzerland51–200Deep Tech, Quantum Computing
Series A·$70.0M·Jan 2022
Viagogo

Online secondary ticket marketplace connecting buyers and sellers for live sports, music, and ent...

Geneva, Switzerland501–1000Marketplace, Media
Series B·$70.0M·Feb 2009
DaedaleanAcquired

AI-based avionics and autonomous flight systems

Zurich, Switzerland11–50Artificial Intelligence, Defense Tech
Series B·$68.0M·Jan 2022
Neo Medical

Value-based care surgical platform for spine surgery, combining AI-driven software, smart modular...

Villette, SwitzerlandMedical Devices, Healthcare
Series B·$68.0M·Sep 2024
Taurus

Digital asset infrastructure provider for institutional investors and banks.

Zurich, Switzerland201–500Fintech, Digital Assets
Series B·$65.0M·Feb 2023
ArpidaClosed

Arpida was a pharmaceutical company focused on drug discovery, formerly VC-backed and headquarter...

Reinach, Switzerland11–50Biotech
Series C·$62.4M·Oct 2005
xFarm Technologies

xFarm Technologies digitizes the agribusiness sector with innovative farm management tools suppor...

Manno, SwitzerlandSaaS
Series C·$62.0M·Oct 2024
HAYA Therapeutics

European biotech therapeutics company.

Lausanne, Switzerland11–50Biotech
Series A·$62.0M·May 2025
ReproNovo

Reproductive health biotechnology company.

Lausanne, Switzerland11–50Biotech, Healthcare
Series A·$62.0M·May 2025
Anjarium BioSciences

Anjarium Biosciences is a Swiss cell and gene therapy tools company enabling next-generation gene...

Schlieren, Switzerland11–50Biotech
Series A·$61.0M·Sep 2021
Verity Studios

Verity Studios creates autonomous indoor drone show systems with choreographed light displays for...

Zurich, Switzerland11–50Defense Tech
Series B·$61.0M·Jul 2023
WINGTRA

Vertical Take-Off and Landing drone for mapping and surveying.

Zurich, Switzerland51–200Defense Tech
Series B·$60.6M·Aug 2024
CorFlow

Changing the paradigm of treatment and diagnosis for heart attack patients

Baar, Switzerland11–50Biotech, Healthcare
Series B·$60.4M·Sep 2024